We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-3.97%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$484B
AUM Growth
-$4.92B
Cap. Flow
+$23.6B
Cap. Flow %
4.87%
Top 10 Hldgs %
31.76%
Holding
15,382
New
1,669
Increased
5,510
Reduced
5,992
Closed
1,922

Sector Composition

Rank Sector Weight
1 Technology 2.72%
2 Healthcare 2.38%
3 Financials 2.3%
4 Consumer Discretionary 1.76%
5 Industrials 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTBL
13076
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$24K ﹤0.01%
408
-558
-58% -$28.4K
KA
13077
PUT
DELISTED
Kineta, Inc. Common Stock
KA
$24K ﹤0.01%
2,243
+743
+50% +$9.12K
GENE
13078
DELISTED
Genetic Technologies Ltd.
GENE
$24K ﹤0.01%
2,392
-4,819
-67% -$46.8K
OTMO
13079
DELISTED
Otonomo Technologies Ltd. Ordinary shares
OTMO
$24K ﹤0.01%
795
-1,816
-70% -$60.5K
NMTR
13080
DELISTED
9 Meters Biopharma
NMTR
$24K ﹤0.01%
2,005
-3,593
-64% -$49.1K
ACOR
13081
CALL
DELISTED
Acorda Therapeutics
ACOR
$24K ﹤0.01%
760
-90
-11% -$3.54K
OBSV
13082
CALL
DELISTED
ObsEva SA Ordinary Shares
OBSV
$24K ﹤0.01%
16,200
-7,600
-32% -$11.2K
AUTO
13083
PUT
DELISTED
AutoWeb, Inc. Common Stock
AUTO
$24K ﹤0.01%
10,400
-12,100
-54% -$32.4K
CTK
13084
DELISTED
CooTek (Cayman) Inc. American Depositary Shares, each representing 650 Class A Ordinary Shares
CTK
$24K ﹤0.01%
+7,124
New +$29.5K
CRBP icon
13085
PUT
Corbus Pharmaceuticals
CRBP
$190M
$23K ﹤0.01%
1,430
-300
-17% -$3.98K
CBIO
13086
CALL
Crescent Biopharma
CBIO
$626M
$23K ﹤0.01%
202
-1,195
-86% -$140K
INBS icon
13087
Intelligent Bio Solutions
INBS
$4.74M
$23K ﹤0.01%
+12
New +$27.6K
JAGX icon
13088
PUT
Jaguar Health
JAGX
$4.67M
0
KA
13089
DELISTED
Kineta, Inc. Common Stock
KA
$23K ﹤0.01%
2,157
-2,082
-49% -$25.6K
ADALW
13090
DELISTED
Anthemis Digital Acquisitions I Corp Warrant
ADALW
$23K ﹤0.01%
87,838
-241,227
-73% -$97.3K
IVC
13091
PUT
DELISTED
Invacare Corporation
IVC
$23K ﹤0.01%
16,300
+6,300
+63% +$13.5K
CRTD
13092
PUT
DELISTED
Creatd Inc. Common Stock
CRTD
$23K ﹤0.01%
20,300
-19,400
-49% -$30.5K
MKD
13093
DELISTED
Molecular Data Inc. American Depositary Shares
MKD
$23K ﹤0.01%
+7,714
New +$21.6K
AVTX icon
13094
Avalo Therapeutics
AVTX
$983M
$22K ﹤0.01%
10
-12
-55% -$30.1K
FTK icon
13095
PUT
Flotek Industries
FTK
$1.28B
$22K ﹤0.01%
2,867
-1,166
-29% -$8.32K
SCLXW icon
13096
Scilex Holding Co Warrant
SCLXW
$22K ﹤0.01%
73,911
+4,200
+6% +$1.23K
AFIB
13097
DELISTED
Acutus Medical Inc
AFIB
$22K ﹤0.01%
15,828
-8,872
-36% -$19K
FSRD
13098
DELISTED
Fast Radius, Inc. Class A Common Stock
FSRD
$22K ﹤0.01%
14,891
-1,650,377
-99% -$8.45M
FTK icon
13099
Flotek Industries
FTK
$1.28B
$21K ﹤0.01%
2,719
-1,776
-40% -$12.7K
IBIO icon
13100
PUT
iBio
IBIO
$70M
$21K ﹤0.01%
97
-10
-9% -$2.09K

Similar funds

Citadel Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Citadel Advisors held 15,382 positions worth $484B, down 1% from $489B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Citadel Advisors deployed $23.6B of net new capital in Q1 2022, opening 1,669 new positions and adding to 5,510 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was NVIDIA, an estimated $518M trimmed.

  • Citadel Advisors's largest Q1 2022 buy was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $555M increase.
  • Citadel Advisors's biggest Q1 2022 reduction was NVIDIA, cutting an estimated $518M.
  • Citadel Advisors fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $535M.
  • Citadel Advisors's ten largest holdings make up 32% of its $484B portfolio in Q1 2022.
  • Citadel Advisors opened 1,669 new positions and closed 1,922 in Q1 2022.
  • Citadel Advisors's portfolio value fell 1% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.